Chemours Company
CC
Market Cap$1.52B
Close$
$-2.31
123.2% downside
Current Fair Value
123.2% downsideOvervalued by 123.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.52 Billion |
|---|---|
| Enterprise Value | $5.49 Billion |
| Dividend Yield | $0.8375 (8.2675222112537%) |
| Earnings per Share | $0.58 |
| Beta | 1.74 |
| Outstanding Shares | 149,918,386 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 48.99 |
|---|---|
| PEG | -45.49 |
| Price to Sales | 0.26 |
| Price to Book Ratio | 3.31 |
| Enterprise Value to Revenue | 0.95 |
| Enterprise Value to EBIT | 16.83 |
| Enterprise Value to Net Income | 176 |
| Total Debt to Enterprise | 0.81 |
| Debt to Equity | 7.66 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Chemours Company
7,000 employees
CEO: Mark Vergnano The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...